期刊文献+

乙型肝炎表面抗原、癌胚抗原与结直肠癌肝转移和预后的关系 被引量:5

HBsAg、CEA and Prognosis and Liver Metastases in Colorectal Cancer
下载PDF
导出
摘要 目的 探讨HBsAg、CEA与结直肠癌肝转移和预后的关系。 方法 回顾性分析 2所医院 1990年 1月~ 1995年 12月间收治的 5 82例结直肠癌的病例资料 ,并对其HBsAg、CEA进行测定 ,分别观察它们与肝转移和预后的关系。 结果 HBsAg阳性者肝转移率明显低于HBsAg阴性者 (P <0 .0 5 ) ;CEA阳性者与CEA阴性者的肝转移率无显著性差异 (P >0 .0 5 ) ,但CEA阳性者的 5年生存率 ( 31.3 % )明显低于CEA阴性者 ( 84.2 % ) (P <0 .0 1)。结论 结直肠癌很少转移至感染乙型肝炎病毒的肝脏 ,CEA不能作为判断结直肠癌肝转移倾向的指标 。 Objective To investigate the relation of HBsAg?CEA and prognosis and liver metastases in colorectal cancer.Methods 582 patients with colorectal cancinoma were analysed retrospectively.Their HBsAg and CEA were assayed before opertion,then the relation of HBsAg?CEA and prognosis and liver metastases were observed respectively.Results The liver metastases rate of colorectal cancer was significantly lower in the patients with HBsAg(+)than in the patients with HBsAg(-)( P <0.05);it was not different in the patients with CEA(+)and CEA(-)( P >0.05),while the 5 years survival rate of patients with CEA (+)was significantly lower than of patients with CEA(-)(31.3% via 84.2% P <0.01).Conclusion Colorectal cancer may rarely metastasize to the liver infected HBsAg;CEA is not a marker to evaluate tendency of liver metastases,but is one of many markers that are used to evaluate the prognosis of colorectal cancer.
出处 《实用癌症杂志》 2001年第5期501-503,共3页 The Practical Journal of Cancer
关键词 乙型肝炎表面抗原 癌胚抗原 结直肠癌 肝转移 结肠癌 预后 直肠癌 HBsAg CEA Colorectal cancer Liver metastases Prognosis
  • 相关文献

参考文献3

二级参考文献1

共引文献15

同被引文献47

  • 1周正,赵恭华,王岩,刘霞,王文跃,潘瑞芹.大肠癌肝转移的临床病理学特点及临床意义[J].中华外科杂志,1995,33(8):454-457. 被引量:6
  • 2雷正明,官德容,张陪明,何友钊,刘宁,李秋.肝转移癌186例诊治分析[J].中国实用外科杂志,1995,15(5):281-282. 被引量:10
  • 3赵平,王成锋,李玉升,李槐.结直肠癌肝转移仍应积极治疗[J].中华医学杂志,2005,85(30):2094-2096. 被引量:17
  • 4杜成雄,冯来运.大肠癌368例癌胚抗原及乙肝病毒检测结果分析[J].人民军医,2005,48(12):703-704. 被引量:3
  • 5Utsunomiya T, Matsumata T. Metastatic carcinoma in the cirrhotic liver. Am J Surg 1993;166:776. 被引量:1
  • 6高桥俊雄.癌転移の機序とその对策.日外会誌 1995;8:539—546. 被引量:1
  • 7Utsunomiya T, Saitsu H, Saku M, Yoshida K, Matsumata T,Shimada M, Sugimachi K. Rare occurrence of colorectal cancer metastasis in livers infected with hepatitis B or C virus.Am J Surg 1999;177:279-281. 被引量:1
  • 8Song E, Chen J, Ou Q, Su F. Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection.Am J Surg 2001;181:529-533. 被引量:1
  • 9Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM. T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995;22:1368-1373. 被引量:1
  • 10Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M. Perforin, Fas/Fas ligand, and TNF-a pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997;158:5283-5291. 被引量:1

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部